News

Niagen joins the portfolio of B-vitamin ingredients that are used in multi-vitamins, nutraceuticals, weight-loss, energy drinks, sports nutrition, meal replacements, and infant formula, food and beverage products. ChromaDex

Using the new system, which does not require any user interaction, an operator can just load a sample and choose a method, while the remaining activity is carried

In October 2012, the facility in Tamil Nadu was inspected and was found to have been breaching quality regulations during drugs manufacturing, as reported by Reuters. The regulator

If approved, Lojuxta will be indicated for adult patients with homozygous familial hypercholesterolemia (HoFH) in all 27 European Union member countries. The medication will be an added therapy

Following extensive research, Crown has claimed to have developed a supplement with superior benefits and efficacy compared to existing supplements. The company believes that the incorporation of new

Indicated for patients with exocrine pancreatic insufficiency (EPI), 36,000 lipase-unit dose of the pancreatic enzyme replacement therapy was approved by the FDA. University of Pittsburgh gastroenterology, hepatology and

According to the strategic alliance, both the organizations will jointly advance the ongoing development of AB-16B5 and distribute the downstream economics on an equal basis in territories outside

Oramed Pharmaceuticals CEO Nadav Kidron said, "This grant will assist Oramed as we initiate Phase 2 clinical trials in the US on our oral insulin candidate." The funds

With the possibility for extension, the patent entitled ‘Fusidic Acid Dosing Regimens for Treatment of Bacterial Infections’ protects US market exclusivity to 2029. Cempra chief executive officer Prabhavathi